Molecular Signature of Clinical Severity in Recovering Patients With Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

BMC Genomics - United Kingdom
doi 10.1186/1471-2164-6-132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prior Immunization With Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected With SARS-CoV

Journal of Immunology
AllergyImmunology
2008English

Serological Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), March 2020

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2020English

Rewiring the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Transcription Circuit: Engineering a Recombination-Resistant Genome

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Using Patient-Collected Clinical Samples and Sera to Detect and Quantify the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

Virology Journal
VirologyInfectious Diseases
2007English

Molecular Mechanisms of Severe Acute Respiratory Syndrome (SARS)

Respiratory Research
PulmonaryRespiratory Medicine
2005English

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Pregnancy in China: A Retrospective Cohort Study

2020English

Severe Acute Respiratory Syndrome (SARS)

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Absence of Contamination of Personal Protective Equipment (PPE) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2020English

Severe Acute Respiratory Syndrome (SARS)

British Journal of Haematology
Hematology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy